News in Science Updates

June 27, 2024

Alzheimer’s vision study improved with home tests

Research looking at the link between Alzheimer’s disease and eye problems is based on ongoing ACT study started in 1994.

Read More

Categories: Science Updates, News


June 20, 2024

Alzheimer’s drug donanemab backed by FDA advisory panel

"Donanemab's compelling clinical trial outcome not only confirms that this treatment strategy is effective in treating Alzheimer's disease, but also provides clinicians additional opportunities to tailor the amyloid monoclonal antibody to the individual patient," said MBWC Clinical Trials Director, Michael Rosenbloom, MD

Read More

Categories: Science Updates, New FDA Drug Approvals, News


February 26, 2024

New Ideas in UW Alzheimer’s Research

Congratulations to the investigators who were awarded 2024-2025 Developmental Project Grants of the UW MBWC’s Alzheimer’s Disease Research Center. These projects will use ADRC resources and participant data in studies on the cutting edge of research into Alzheimer’s and related dementias.

Read More

Categories: Science Updates, News


January 31, 2024

A 2024 New Year’s Update and Thank You to UW ADRC research participants

Members of the ADRC team wish you a happy and healthy new year! We would like to update you on our progress and express how much we appreciate your ongoing participation. Enjoy this video!

Read More

Categories: Science Updates, New FDA Drug Approvals, En Español


December 04, 2023

UW Medicine’s Memory and Brain Wellness Center treated its first patient with the new Alzheimer’s drug, lecanemab

The drug has been shown to reduce cognitive decline in patients with early Alzheimer's.

Read More

Categories: Science Updates, New FDA Drug Approvals, News


November 29, 2023

Discoveries Made Possible By You // Fall 2023

For these studies, researchers used data from participants in the UW ADRC Clinical Core, with gratitude.

Read More

Categories: Science Updates, News


Highlights from the 2023 Alzheimer’s Association International Conference

Dr. Angela Hanson's lab team reports back on interesting talks about what’s coming soon in diagnosis, treatment, and prevention of Alzheimer’s and other diseases that lead to cognitive impairment and dementia.

Read More

Categories: Science Updates, New FDA Drug Approvals, Care & Treatment , News


November 21, 2023

Sleep doctor studies sleep apnea treatment for dementia prevention

The brain’s ability to clear out waste products during deep sleep is important for brain health. “People with untreated sleep-related breathing disorders are losing that chance to fully regenerate their bodies at night,” says Cho. “I feel so bad when I see this happening because this problem can be treated.”

Read More

Categories: Science Updates, Care & Treatment , News


October 04, 2023

REC Symposium Brings Together UW Alzheimer’s Research Community

A day of learning and sharing the newest ADRC work in progress, with food and fun mixed in. Being in person together is what this annual event is all about.

Read More

Categories: Science Updates, News


September 25, 2023

Spotlight on Dr. Jeanne Gallée and the Role of Speech-Language Services in Dementia Care

“I would say the role of a speech language pathologist is to untap someone's functional communication abilities and allow them to express themselves in ways that leave them feeling successful,” says speech-language pathologist Jeanne Gallée, PhD, CCC-SLP, a new ADRC co-investigator and trainee in the ADRC Research and Education Component.

Read More

Categories: Science Updates, Care & Treatment , Team Spotlights, Resources, News